Updated initial conversion table based on clinical trials in adults showing significantly improved mealtime glycemic ...

The FDA has approved a label update for an inhaled insulin indicated for adults with type 1 or type 2 diabetes, according to ...

New Afrezza prescribing information outlines higher starting dose conversions for patients transitioning from mealtime ...

Dublin, Jan. 20, 2026 (GLOBE NEWSWIRE) -- The "Insulin Pumps & Continuous Glucose Monitors Market Size by Segments, Share, Regulatory, Reimbursement and Forecast to 2036" report has been added to ...

Investing.com -- MannKind Corporation (NASDAQ:MNKD) stock rose 3.5% Monday after the company announced that the U.S. Food and Drug Administration (FDA) approved an update to the prescribing ...

Insulet Corporation (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced its transformative Omnipod 5 Automated Insulin ...

MannKind Corporation (NASDAQ:MNKD) shares gained 3.5% on Monday after the company said the U.S. Food and Drug Administration ...

Issued on behalf of Avant Technologies Inc. VANCOUVER, BC, Jan. /CNW/ — USA News Group News Commentary – Global capital is officially rotating into “Longevity Infrastructure” which is ...

Shares of MannKind Corp. (MNKD) gained more than 7% in pre-market trading on Monday after the company announced that the U.S.

The Global Prefilled Auto Injectors Market is projected to grow at a CAGR of 8.4% from 2026 to 2033, according to a new report published by Verified Market Reports®. The report reveals that the market ...

MannKind (Nasdaq:MNKD) announced today that it received FDA approval, updating the prescribing information for Afrezza ...